Company Badge
USPTO Data Jan 1 1976 - Nov 3 2026
6 Patents
#93 in Rockville, MD
#635 in Maryland
#45,027 in US
Teva Biopharmaceuticals USA, Inc.
Forward Citations = 99
9 inventors:
Rockville, MD, United States of America
Teva Biopharmaceuticals USA, Inc.
Calculating rank
% Expired Patents = 33.3
EPO Patents = 1
Forward Citations = 99
Loading Chart...
Loading Chart...
9 inventors (with patents filed for the assignee):
Palanisamy Kanakaraj (5 out of 5 patents)
Viktor Roschke (5 out of 18 patents)
Craig A Rosen (5 out of 329 patents)
4. Rodger G Smith (5 out of 14 patents)
5. Bridget A Cooksey (3 out of 3 patents)
6. Bridget Ann Cooksey (1 out of 10 patents)
7. Adam C Bell (1 out of 1 patent)
8. Indrajit Sanyal (1 out of 1 patent)
9. Qinghai Zhao (1 out of 1 patent)
10. Rodger Smith (0 patent)
6 patents:
Company Overview
Teva Biopharmaceuticals USA, Inc. is a leading global pharmaceutical company focused on the development, production, and marketing of high-quality biopharmaceutical products. With a strong commitment to innovation and scientific excellence, Teva Biopharmaceuticals USA is dedicated to improving the lives of patients worldwide through advanced biologic therapies.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Teva Biopharmaceuticals USA, Inc.. Retrieved from https://idiyas.com/company/teva-biopharmaceuticals-usa
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
1 patent (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]